Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
04/2012
04/17/2012CA2506672C Il-23 for treating cutaneous wounds
04/12/2012US20120088695 Method and Device for Protein Delivery into Cells
04/12/2012US20120087936 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
04/12/2012US20120087925 Method for the treatment of inflammatory disorders
04/12/2012US20120087918 Methods and compositions for inhibiting the growth of hematopoietic malignant cells
04/11/2012EP2438925A2 Compounds that modulate neuronal growth and their uses
04/11/2012EP1675552B1 Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors
04/11/2012EP1503794B1 Methods of treatement using ctla-4 antibodies
04/11/2012CN1984926B Fsh糖基化突变体 Fsh glycosylation mutants
04/10/2012US8153684 Use of equol for treating androgen mediated diseases
04/10/2012US8153657 Dopamine-, norepinephrine- and serotonin-transporter-selective heterocyclic compounds and their therapeutic applications
04/10/2012US8153631 Triazole compounds and uses related thereto
04/10/2012US8153608 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
04/10/2012US8153591 Protein biomaterials and biocoacervates and methods of making and using thereof
04/10/2012US8153170 compositions of Acai fruit and Jucara fruit with high antioxidant capability and cyclooxygenase-inhibitory activity, and their uses
04/10/2012CA2528483C Compositions and methods for increasing telomerase activity
04/10/2012CA2514124C Absorption enhancing agents
04/05/2012US20120083428 Method and Device for Protein Delivery into Cells
04/05/2012US20120082725 Composition Comprising Immunogenic Microparticles
04/04/2012EP2436774A2 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
04/04/2012EP1660513B9 A ca6 antigen-specific cytotoxic conjugate and methods of using the same
04/04/2012EP1615878B1 Compounds, compositions and methods of treatment for heart failure
04/04/2012CN101404892B Microcrystalline cewllulose compositions
03/2012
03/29/2012US20120077871 9, 10-Alpha, Alpha-OH-Taxane Analogs and Methods for Production Thereof
03/29/2012US20120077862 Antisense modulation of ptp1b expression
03/29/2012US20120077754 Copolymer-1 improvements in compositions of copolymers
03/29/2012US20120076835 Hiv inhibiting pyrimidines derivatives
03/29/2012US20120076764 Methods and pharmaceutical compositions for healing wounds
03/28/2012EP2433946A1 LPA receptor agonists and antagonists and methods of use
03/28/2012EP1663175B1 Oral drug delivery system
03/28/2012CN1822827B Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition
03/27/2012US8143366 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same
03/27/2012US8143286 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione)
03/27/2012US8143261 Thiazolo (4,5-D) pyrimidine compounds
03/27/2012US8143239 Composition for inhalation
03/27/2012US8142819 Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
03/27/2012US8142778 Methods of treatment using CTLA-4 antibodies
03/27/2012US8142763 Pressurized metered dose inhalers (MDI) containing a solution comprising ipratropium bromide, HFA propellant, and co-solvent and comprising a container with a specific internal surface composition and/or lining
03/27/2012CA2540541C Alkoxy substituted imidazoquinolines
03/27/2012CA2521784C Reversible pegylated drugs
03/22/2012WO2005032457A3 Vectors and methods for immunization against norwalk virus using transgenic plants
03/22/2012WO2004050019A9 Method and compositions for treating anxiety
03/22/2012US20120071537 New Oral Formulation
03/22/2012US20120071429 Novel antibacterial agents
03/22/2012US20120070437 Method of identifying compounds that bind baff-r
03/21/2012EP1320540B9 Peptidomimetic protease inhibitors
03/21/2012CN101366989B Dry powder inhalation system for transpulmonary dosage
03/21/2012CN101130071B Vaccine
03/20/2012US8138328 Modulation of apolipoprotein (A) expression
03/20/2012US8138305 Glucagon-like peptide-1 (glp-1) receptor agonist; diabetes, obesity, glucagonomas, secretory disorders of the airway, metabolic disorder, arthritis, osteoporosis, central nervous system disease, restenosis and neurodegenerative disease.
03/20/2012CA2514507C Methods and compositions for the treatment of gastrointestinal disorders
03/20/2012CA2405076C Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof
03/20/2012CA2351580C Stabilization of macrolides
03/15/2012US20120065365 Stable Radiopharmaceutical Compositions and Methods for Their Preparation
03/15/2012US20120065237 Methods for treating transthyretin amyloid diseases
03/15/2012US20120065154 Pyrazolo Pyrimidine Derivatives and Methods of Use Thereof
03/15/2012US20120065149 Vitamin receptor binding drug delivery conjugates
03/15/2012US20120064083 Therapeutic use of anti-cs1 antibodies
03/15/2012US20120064034 Peptidomimetic protease inhibitors
03/14/2012EP2428516A1 Novel phosphorus-containing thyromimetics
03/14/2012EP1622632B1 Jucara and acai fruit-based dietary supplements
03/14/2012CN1871003B Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
03/13/2012US8133981 Therapeutic use of anti-CS1 antibodies
03/13/2012US8133876 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
03/13/2012CA2419607C Peptidomimetic protease inhibitors
03/08/2012US20120059358 Dna vaccines encoding heat shock proteins
03/08/2012US20120058083 Therapies for Chronic Inflammatory Demyelinating Polyneuropathy Using Interferon-Beta
03/07/2012EP2426118A1 Methods of making the polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
03/07/2012EP2425848A2 Influenza immunogen and vaccine
03/07/2012EP2425836A1 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
03/07/2012EP1583506B1 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
03/07/2012CN1791418B Nutrition replenisher for jucara and acai fruit group
03/07/2012CN101381339B Prodrugs of gaba analogs, compositions and uses thereof
03/06/2012US8129422 Methods and compositions for increasing the anaerobic working capacity in tissues
03/06/2012US8129382 Compounds, methods and pharmaceutical compositions for inhibiting PARP
03/06/2012US8129359 Composition and method for treating post-surgical pain
03/06/2012US8128928 Humanized antibodies that recognize beta amyloid peptide
03/06/2012CA2544232C Method for producing abrasive non-woven cloth
03/06/2012CA2525628C New benzimidazole derivatives
03/06/2012CA2523245C Indole acetic acid derivatives and their use as pharmaceutical agents
03/06/2012CA2370697C Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
03/01/2012US20120052044 Uses of mammalian cytokine; related reagents
03/01/2012US20120052016 Reconstitutable Microsphere Compositions Useful As Ultrasonic Contrast Agents
02/2012
02/29/2012CN1972713B Pharmaceutical composition for treating or preventing cardiac dysfunction
02/29/2012CN101574347B Aripiprazole medicinal agent of low hygroscopicity and methods for its preparing
02/29/2012CN101287483B Pharmaceutical compositions and methods for accelerating wound healing
02/28/2012US8124687 Random ethylene oxide copolymer and non-random alkylene oxide(s) polymer with bioactive agent
02/28/2012US8124626 Methods of treating inflammations and infections with pyridinium salts
02/28/2012US8124378 Murine zcytor17 ligand polynucleotides
02/28/2012US8124330 Screening methods for cognitive enhancers
02/28/2012US8124141 Rapidly absorbing lipophilic skin compositions and uses therefor
02/28/2012US8124105 Compositions, methods and kits relating to poxvirus subunit vaccines
02/28/2012US8124070 Probiotics for pet food applications
02/28/2012US8124068 Recombinant intracellular pathogen immunogenic compositions and methods of use
02/28/2012CA2503361C Controlled-release compositions
02/23/2012US20120046316 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
02/23/2012US20120046276 Tuberculosis treatment using pleuromutilin derivatives
02/23/2012US20120045471 Recombinant parainfluenza virus vaccine comprising heterologous antigens derived from respiratory syncytial virus
02/22/2012EP2420249A1 Vaccine immunotherapy for immune suppressed patients
02/22/2012EP1691836B1 Anti-pecam therapy for metastasis suppression
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 295